Adverse events402

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

21 to 40 of 402

Download this page as JSON

Type	Event	Organ system	Group	Affected	At risk	Events
other	Dysgeusia	Nervous system disorders	GSK525762 40 mg+Abiraterone 1000 mg	2	4	3
other	Dysgeusia	Nervous system disorders	GSK525762 80 mg+Enzalutamide 160 mg	2	10	5
other	Dysgeusia	Nervous system disorders	GSK525762 60 mg+Enzalutamide 160 mg	7	22	11
other	Dysgeusia	Nervous system disorders	GSK525762 60 mg Alternate+Enzalutamide 160 mg	10	21	11
other	Asthenia	General disorders	GSK525762 60 mg+Abiraterone 1000 mg	0	10	0
other	Asthenia	General disorders	GSK525762 60 mg Alternate+Abiraterone 1000 mg	3	6	4
other	Asthenia	General disorders	GSK525762 40 mg+Abiraterone 1000 mg	4	4	5
other	Asthenia	General disorders	GSK525762 80 mg+Enzalutamide 160 mg	2	10	7
other	Asthenia	General disorders	GSK525762 60 mg+Enzalutamide 160 mg	8	22	11
other	Asthenia	General disorders	GSK525762 60 mg Alternate+Enzalutamide 160 mg	11	21	14
other	Diarrhoea	Gastrointestinal disorders	GSK525762 60 mg+Abiraterone 1000 mg	3	10	3
other	Diarrhoea	Gastrointestinal disorders	GSK525762 60 mg Alternate+Abiraterone 1000 mg	2	6	2
other	Diarrhoea	Gastrointestinal disorders	GSK525762 40 mg+Abiraterone 1000 mg	2	4	5
other	Diarrhoea	Gastrointestinal disorders	GSK525762 80 mg+Enzalutamide 160 mg	2	10	3
other	Diarrhoea	Gastrointestinal disorders	GSK525762 60 mg+Enzalutamide 160 mg	6	22	10
other	Diarrhoea	Gastrointestinal disorders	GSK525762 60 mg Alternate+Enzalutamide 160 mg	7	21	10
other	Vomiting	Gastrointestinal disorders	GSK525762 60 mg+Abiraterone 1000 mg	5	10	6
other	Vomiting	Gastrointestinal disorders	GSK525762 60 mg Alternate+Abiraterone 1000 mg	1	6	1
other	Vomiting	Gastrointestinal disorders	GSK525762 40 mg+Abiraterone 1000 mg	0	4	0
other	Vomiting	Gastrointestinal disorders	GSK525762 80 mg+Enzalutamide 160 mg	2	10	2

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Previous page Next page

Sources 3

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03150056/events?page=2

API reference For AI assistants